22 results
424B5
SCTL
Societal CDMO Inc
25 Aug 23
Prospectus supplement for primary offering
8:06pm
or activist shareholders.
These broad market and industry factors may decrease the market price of our common stock, regardless of our actual operating
424B5
SCTL
Societal CDMO Inc
23 Aug 23
Prospectus supplement for primary offering
4:38pm
shareholders;
our announcement of financing transactions, including debt, convertible notes, etc.; and
actions by institutional or activist shareholders
424B5
SCTL
Societal CDMO Inc
13 Dec 22
Prospectus supplement for primary offering
5:29pm
, convertible notes, etc.; and
actions by institutional or activist shareholders.
These broad market and industry factors may decrease the market price
424B5
SCTL
Societal CDMO Inc
13 Dec 22
Prospectus supplement for primary offering
5:26pm
of financing transactions, including debt, convertible notes, etc.; and
actions by institutional or activist shareholders.
These broad market
424B5
rezp7 p07hgq6b11h
12 Dec 22
Prospectus supplement for primary offering
7:16am
424B5
6rfu3re6wlyfrgr1s
12 Dec 22
Prospectus supplement for primary offering
7:12am
424B5
lgbm2xu
13 May 21
Prospectus supplement for primary offering
12:00am
424B5
ivp4u
11 May 21
Prospectus supplement for primary offering
5:29pm
424B5
ixsls37a p2rhg
26 Feb 21
Prospectus supplement for primary offering
5:30pm
424B5
9jz6 9kzc2272dd
10 Aug 20
Prospectus supplement for primary offering
8:00am
DEFA14A
bg60efgpovyc nn3
28 Mar 19
Additional proxy soliciting materials
12:46pm
8-K
EX-99.1
hrybx
28 Mar 19
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
6:05am
8-K
wp9in63p01hw17xiba
28 Mar 19
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
6:05am